This study is currently not recruiting participants.
"Enhancing Preventive Therapy of Malaria In children with Sickle cell anemia in East Africa (EPiTOMISE) A randomized trial of daily Proguanil monthly Sulfadoxine/Pyrimethamine-Amodiaquine or monthly Dihydroartemsinin-Piperaquine for the prevention of malaria in children with sickle cell anemia in Homa Bay Kenya"
Not Recruiting
100 years or below
All
Phase
N/A
Brief description of study.
In this study, we are going to compare three malaria drugs that are already available in your local pharmacy in order to see which of the medications, if any, is better at reducing the number of times your child has malaria.
Detailed description of study
In this study, we are going to compare three malaria drugs that are already available in your local pharmacy in order to see which of the medications, if any, is better at reducing the number of times your child has malaria.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Malaria
Age:
100 years or below
Gender: All
Updated on
10 Jan 2018.
Study ID: 1712295578 (IUSCC-0650)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
